Evaluation of plasma treatment effects on improving adhesive-dentin bonding by using the same tooth controls and varying cross-sectional surface areas.

The objective of this study was to evaluate and verify the effectiveness of plasma treatment for improving adhesive-dentin interfacial bonding by performing microtensile bond-strength (µTBS) testing using the same-tooth controls and varying cross-sectional surface areas. Extracted unerupted human third molars were used after removal of the crowns to expose the dentin surface. One half of each dentin surface was treated with a non-thermal argon plasma brush, whilst the other was shielded with glass slide and used as an untreated control. Adper Single Bond Plus adhesive and Filtek Z250 dental composite were then applied as directed. The teeth thus prepared were further cut into micro-bar specimens, with cross-sectional sizes of 1 × 1 mm², 1 × 2 mm², and 1 × 3 mm², for µTBS testing. The test results showed that plasma-treated specimens gave substantially stronger adhesive-dentin bonding than their corresponding same-tooth controls. Compared with their untreated controls, plasma treatment gave statistically significant higher bonding strength for specimens with a cross-sectional area of 1 × 1 mm² and 1 × 2 mm², with mean increases of 30.8% and 45.1%, respectively. Interface examination using optical and electron microscopy verified that plasma treatment improved the quality of the adhesive-dentin interface by reducing defects/voids and increasing the resin tag length in dentin tubules.

Inhibition of Staphylococcus epidermidis biofilm by trimethylsilane plasma coating.

Biofilm formation on implantable medical devices is a major impediment to the treatment of nosocomial infections and promotes local progressive tissue destruction. Staphylococcus epidermidis infections are the leading cause of biofilm formation on indwelling devices. Bacteria in biofilms are highly resistant to antibiotic treatment, which in combination with the increasing prevalence of antibiotic resistance among human pathogens further complicates treatment of biofilm-related device infections. We have developed a novel plasma coating technology. Trimethylsilane (TMS) was used as a monomer to coat the surfaces of 316L stainless steel and grade 5 titanium alloy, which are widely used in implantable medical devices. The results of biofilm assays demonstrated that this TMS coating markedly decreased S. epidermidis biofilm formation by inhibiting the attachment of bacterial cells to the TMS-coated surfaces during the early phase of biofilm development. We also discovered that bacterial cells on the TMS-coated surfaces were more susceptible to antibiotic treatment than their counterparts in biofilms on uncoated surfaces. These findings suggested that TMS coating could result in a surface that is resistant to biofilm development and also in a bacterial community that is more sensitive to antibiotic therapy than typical biofilms.